- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Aimil Pharmaceuticals(India) Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (31), financial health (75), director (95) and company-foundation signals.
- Operating for 41+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2023 - filings look overdue.
- Profitable in FY 2023.
- Positive net worth.
- 6 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) Limited is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN U24231DL1984PLC019461). Business overview includes Healthcare (Ayurvedic Products & Services), incorporated on November 30, 1984 (42+ years old), headquartered in New Delhi, Delhi, India. The company is currently Active with Active Compliant compliance status.
- Location 2994/4 Street No 17Ranjeet Nagar, New Delhi, Delhi - 110008
- Website aimilpharmaceuticals.com
Financial Performance of Aimil Pharmaceuticals(India) Limited
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Aimil Pharmaceuticals(India) Limited (6)
Charges of Aimil Pharmaceuticals(India) Limited
| Lender | Amount | Status |
|---|---|---|
|
Tata Capital Financial Services Limited
Creation Date: 08 Sep 2023 |
1.75 cr | Open |
|
Others
Creation Date: 29 Oct 2021 |
13.75 cr | Open |
|
Others
Creation Date: 08 Oct 2021 |
34.75 Lakh | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
